Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinoma
===============================================================================================================================================================================================================

* Sonia Simonetti
* Michele Iuliani
* Marco Stellato
* Silvia Cavaliere
* Bruno Vincenzi
* Giuseppe Tonini
* Daniele Santini
* Francesco Pantano